Intelligent Bio Solutions Inc. (INBS) vs enVVeno Medical Corporation (NVNO)
A side-by-side comparison of Intelligent Bio Solutions Inc. and enVVeno Medical Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INBS
Intelligent Bio Solutions Inc.
$1.59HealthcareDelayed quote: Oct 6, 2026, 11:32 AM EDT
NVNO
enVVeno Medical Corporation
$8.58HealthcareDelayed quote: Oct 6, 2026, 11:33 AM EDT
Total return — INBS vs NVNO
growth of $100 · dividends reinvested · last 6yINBS -100.0% (-80.0%/yr)NVNO -97.1% (-44.6%/yr)NVNO compounded faster over this window
Log scale — wide-divergence pair
INBS NVNO
INBS vs NVNO: by the numbers
- •NVNO is the larger company ($6M vs $5M market cap).
- •Both run net losses; NVNO's is the smaller (0.00% vs -294.91% net margin).
Metrics side by side
Valuation
| Metric | INBS | NVNO |
|---|---|---|
| P/S ratio | 1.25 | N/A |
| P/B ratio | 0.96 | 0.29 |
Profitability
| Metric | INBS | NVNO |
|---|---|---|
| Gross margin | 48.63% | 0.00% |
| Operating margin | -305.03% | 0.00% |
| Net margin | -294.91% | 0.00% |
| ROE | -225.57% | -76.07% |
| ROIC | -179.58% | -80.65% |
Growth (annualized)
| Metric | INBS | NVNO |
|---|---|---|
| Revenue CAGR (5Y) | 19.95% | N/A |
| Total return CAGR (5Y) | -80.26% | -52.99% |
Frequently asked
- How have INBS and NVNO total returns compared?
- Over the past 5 years, INBS delivered -80.26% and NVNO delivered -52.99% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Intelligent Bio Solutions ROEenVVeno Medical ROEIntelligent Bio Solutions operating marginenVVeno Medical operating marginIntelligent Bio Solutions revenue growthenVVeno Medical revenue growthIntelligent Bio Solutions free cash flowenVVeno Medical free cash flow
Intelligent Bio Solutions & enVVeno Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.